Fidelity Investments
SVRA icon

Fidelity Investments’s Savara SVRA Stock Holding History

Fidelity Investments’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
174,738
+105,707
+153% +$567K ﹤0.01% 2986
2026
Q1 		$377K Buy
69,031
+41,182
+148% +$229K ﹤0.01% 3232
2025
Q4 		$168K Buy
27,849
+20,647
+287% +$101K ﹤0.01% 3515
2025
Q3 		$25.7K Buy
7,202
+1,551
+27% +$4.59K ﹤0.01% 4260
2025
Q2 		$12.9K Sell
5,651
-7,431
-57% -$20.2K ﹤0.01% 4446
2025
Q1 		$36.2K Sell
13,082
-1,040,426
-99% -$2.87M ﹤0.01% 3994
2024
Q4 		$3.23M Sell
1,053,508
-30,385
-3% -$106K ﹤0.01% 2296
2024
Q3 		$4.6M Buy
1,083,893
+95,154
+10% +$420K ﹤0.01% 2156
2024
Q2 		$3.98M Buy
988,739
+986,724
+48,969% +$4.39M ﹤0.01% 2149
2024
Q1 		$10K Sell
2,015
-287
-12% -$1.39K ﹤0.01% 4275
2023
Q4 		$10.8K Sell
2,302
-1,739
-43% -$6.67K ﹤0.01% 4216
2023
Q3 		$15.3K Buy
4,041
+2,156
+114% +$7.69K ﹤0.01% 3936
2023
Q2 		$6.02K Buy
1,885
+117
+7% +$275 ﹤0.01% 4307
2023
Q1 		$3.45K Buy
1,768
+96
+6% +$216 ﹤0.01% 4482
2022
Q4 		$2.59K Hold
1,672
– – ﹤0.01% 4449
2022
Q3 		$3K Hold
1,672
– – ﹤0.01% 4494
2022
Q2 		$3K Sell
1,672
-76
-4% -$100 ﹤0.01% 4494
2022
Q1 		$2K Buy
+1,748
New +$2.11K ﹤0.01% 4710
2021
Q4 		– Sell
-2,000
Closed -$3K – 4906
2021
Q3 		$3K Buy
2,000
+1,999
+199,900% +$2.7K ﹤0.01% 3932
2021
Q2 		$0 Buy
+1
New +$2 ﹤0.01% 4846
2020
Q4 		– Sell
-6
Closed – – 4265
2020
Q3 		$0 Buy
+6
New +$10 ﹤0.01% 3983
2019
Q4 		– Sell
-345,588
Closed -$916K – 4246
2019
Q3 		$916K Sell
345,588
-28,208
-8% -$70.5K ﹤0.01% 2438
2019
Q2 		$886K Buy
373,796
+246
+0.1% +$2.19K ﹤0.01% 2469
2019
Q1 		$2.75M Sell
373,550
-268
-0.1% -$2.02K ﹤0.01% 2230
2018
Q4 		$2.83M Buy
+373,818
New +$3.36M ﹤0.01% 2203
2013
Q4 		– Sell
-14,961
Closed -$460K – 2683
2013
Q3 		$460K Sell
14,961
-15
-0.1% -$466 ﹤0.01% 2514
2013
Q2 		$450K Buy
+14,976
New +$665K ﹤0.01% 2486

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Fidelity Investments's SVRA Position: Q2 2026 in Review

Fidelity Investments increased its Savara (SVRA) stake by 153% in Q2 2026, buying an estimated $567K and bringing the position to 174,738 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2986.

Fidelity Investments first reported a position in SVRA in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.6M in Q3 2024. 180 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • Fidelity Investments held 174,738 shares of Savara worth $1.08M as of Q2 2026.
  • Fidelity Investments bought 105,707 Savara shares in Q2 2026, an estimated $567K.
  • Savara made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2986 holding.
  • Fidelity Investments first reported a position in Savara in Q2 2013 and has held it in 27 quarters since.
  • Fidelity Investments's Savara position peaked at $4.6M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.